Exacerbation of pre-existing liver disease after halothane anaesthesia has been reported in adult patients. A prospective study was performed in 38 children with biopsy-proven liver disease to assess the effect of surgery and halothane anaesthesia on liver function. Plasma liver enzyme levels were measured immediately preoperatively and again four to eight days after surgery and halothane anaesthesia. Minor elevations of both AST and ALT occurred in four patients but this was not associated with a clinical deterioration in the patients' postoperative recovery. In the children studied pre-existing liver disease did not predispose to a deterioration of liver function following surgery and halothane anaesthesia.
Halothane is the most common volatile anaesthetic agent used in paediatric anaesthesia. 1 In children anaesthetised with halothane twice within a month, 4-10% develop minor disturbances of serum liver enzymes. 2 In rare instances acute hepatic failure has been reported after the use of halothane in children. 3·6 Camilleri, Victorino and Hodgson 7 reported a 33-year-old woman with chronic liver disease who suffered a deterioration of liver function after exposure to halothane anaesthesia. Tanifuji and colleagues 8 compared the hepatotoxicity of halothane and enflurane in 26 patients with hepatic cirrhosis who presented for transoesophageal varix ligation. The enflurane group did not show any significant change in plasma aspartate aminotransferase (AST) or alanine aminotransferase (AL T) levels whereas the halothane group showed a five-fold rise in AST levels and a three-and-a-half times elevation in ALT levels on the first postoperative day.
It has been suggested that halothane should be used with extreme caution in children with liver damage 9 and that the newer, less biotransformed volatile agents are to be preferred to halothane in patients suspected of having liver disease. 10 Strunin and co-workers 11 ,12 state that patients with pre-existing liver disease are at no greater risk than other patients of developing unexplained hepatitis following halothane.
A prospective study was conducted to assess the effect of surgery and halothane anaesthesia on liver function in children with biopsy-proven liver disease.
PATIENTS AND METHOD
The study was performed at the Royal Alexandra Hospital for Children, Sydney in the four-year period June 1984 to June 1988. Approval for the study was obtained from the Hospital Ethics Committee. Children with biopsy-proven liver disease and children with liver disease scheduled for liver biopsy as part of the operative procedure were included in the investigation.
Blood was taken one or two days preoperatively for baseline liver function tests. Premedication was with intramuscular omnopon 300 Ilg.kg-l and scopolamine 6 Ilg.kg-l; pethidine 1 mg.kg-l and atropine 12 Ilg.kg·l; atropine 20 Ilg.kg-l or nothing depending on the preferences of the child, the parents and the anaesthetist. Induction was with either nitrous oxide, oxygen and halothane or thiopentone 5 mg.kg-l. The patient was paralysed with alcuronium 300 Ilg.kg·l and intubated with an endotracheal tube which allowed a small leak at 10 centimetres of water pressure. For children less than 25 kg an Ayre's T-piece was used and for patients over this weight a circle absorber was used. Ventilation was with a Campbell (Uleo Engineering, Sydney) pressure-limited time-cycled ventilator. The inspiratory gas mixture consisted of nitrous oxide, oxygen and halothane. End-tidal carbon dioxide and halothane concentrations were not measured. The adequacy of ventilation was assessed visually and by auscultation. A detailed record of the duration and concentration of halothane administered was kept. An indication of the extent of patient exposure to halothane was obtained by multiplying percent concentration used by duration of administration.
The units of the value obtained were expressed as percent hours. Blood pressure and electrocardiogram were monitored and a precordial stethoscope used. Anaesthesia proceeded uneventfully in all patients and hypotension, hypoxia and hypovolaemia were not observed either intraor postoperatively.
At the conclusion of surgery paralysis was reversed with neostigmine 50 ~g.kg-I and atropine 20 ~g.kg-I. Patients were extubated awake after regular spontaneous respiration was established. Blood for liver function tests was taken four to eight days postoperatively. The timing of the blood sample was at the discretion of the consultant surgeon responsible for the patient's care. No blood was taken solely for the purpose of the study.
Laboratory Tests
To assess plasma liver enzyme levels a 2 ml sample of blood was taken into a heparinized vial. The blood was centrifuged within one hour of collection and the plasma stored at 4°C. Liver function tests were performed within 24 hours of blood collection. All tests were performed at the hospital biochemistry department by JE who had no knowledge of the patient's anaesthetic history.
Serum bilirubin concentration was determined using the method of Jendrassick and Grof. Serum concentrations of aspartate aminotransferase (AST), alanine aminotransferase (AL T), gamma glutamyl transferase (GGT) and alkaline phosphate (SAP) were determined using an IL Mutistat III auto analyser. Not all tests were performed on each blood sample. The concentrations ofliver enzymes were measured at 37°C and the results reported in units/litre. The criterion for a change in enzyme concentration was that the value after anaesthesia varied from the preoperative value by more than three standard deviations for the method of analysis. The standard deviation of the method of analysis was calculated from the coefficient of variation of several hundred repeated estimations on 'control' sera over the period of the study and is expressed at the upper limit of the 'normal' range. The 'normal' enzyme ranges and corresponding standard deviations are shown in Table 1 . 
RESULTS

Clinical Details
The clinical details of patients included in the study are shown in Table 2 . Ages ranged from two months to eighteen years, weights from 3.3 kg to 50 kg and exposure to halothane from 0.5 to 2.6 percent hours. Thirty-eight children were studied on 76 occasions. Postoperative blood samples were not obtained eleven times. On nine occasions patients who had a percutaneous transhepatic cholangiogram performed were discharged from hospital the day following surgery and a postoperative blood sample was not taken. Two patients who had a feeding gastrostomy performed did not have postoperative blood samples taken.
Twenty-one ofthe 38 patients had cystic fibrosis with liver disease secondary to obstruction of the intrapancreatic common bile duct. Typically the liver biopsy showed focal cirrhosis, a few mucous plugs consistent with cystic fibrosis, patchy acuteon-chronic cholangitis and marked bile duct proliferation. In patients with cystic fibrosis the preoperative arterial haemoglobin oxygen saturation in room air as assessed with a pulse oximeter ranged from 91-97%. Thirty-six patients had liver disease secondary to extrahepatic bile duct obstruction. In some patients the liver biopsy was consistent with superimposed acute biliary tract infection. Two of the 38 patients studied had hepatic parenchymal disease. A fivemonth-old boy had a neuroblastoma infiltrating the liver and a two-month-old girl had atypical neonatal hepatitis. Seven patients with biliary atresia were treated with phenobarbitone to induce liver enzymes and improve bilirubin metabolism.
Fifteen patients had at least two anaesthetics within a month for the investigation and treatment of their liver disease.
Alteration oj liver junction tests
The alterations of liver function tests after surgery and halothane anaesthesia in patients with biopsy-proven liver disease are shown in Tables 3-6. The highest percentage elevation of postoperative liver function tests occurred in a twelve-year-old boy with cystic fibrosis and obstruction of the common bile duct who had a percutaneous transhepatic cholangiogram and needle liver biopsy under general anaesthesia. Blood was taken two days before and seven days after the investigation. The alterations of liver function tests were AST from 41 to 164 VII, ALT from 53 to 135 VII GGT from 288 to 299 VII and SAP from 90 to 51 VII. Seventeen days following cholangiography the patient had a cholecystojejunostomy and was exposed to 1.5 per cent hours of halothane. Five days postoperatively the liver function tests were AST 71 VII, ALT 75 VII, GGT 215 VII and SAP 84 VII. Fourteen days postoperatively the liver function tests were AST 35 VII, ALT 35 VII, GGT 223 VII and SAP 78
VII.
One infant with biliary atresia had seven operations in the first nine months of life and all anaesthetics included halothane. No statistically t Not all liver function tests were performed on each blood sample. j The value after anaesthesia changed from the preoperative value by more than three standard deviations of the method of analysis. significant change in liver function tests following surgery and anaesthesia occurred. The highest elevation of preoperative liver enzymes was in a 29-month-old girl with a choledochal cyst, AST was 497 VII, ALT 474 VII and GGT 1264 VII. She was exposed to three halothane anaesthetics within six weeks with a total exposure to halothane of 3.2 per cent hours.
Liver function tests taken on the fourth postoperative day after her last operation, which lasted 255 minutes, were AST 44 VII, ALT 56 VII and GGT 60 VII.
One 45-month-old girl was kicked in the abdomen by a horse six months before admission. Her liver function tests on admission were total bilirubin 248 J.1mol.l-1 direct bilirubin 132 J.1moU-l , AST 475 VII, ALT 398 VII, GGT 2178 VII and SAP 500 VII. Investigations showed a completely obstructed common bile duct and in the course of seven weeks she had three halothane anaesthetics. Seven days after her last operation, a choledochojejunostomy, where she was exposed to 2.0 percent hours of halothane, her liver function tests were total bilirubin 23 J.1moU-1 direct bilirubin 14 J.1mol-l , AST 64 VII, ALT 40 VII, GGT 263 VII and SAP 130 VII.
DISCUSSION
Two retrospective studies, one in children l3 and one in adults, 14 have examined the use of halothane in patients with pre-existing liver disease. The authors noted that none of the patients undergoing t Not all liver function tests were performed on each blood sample. j The value after anaesthesia changed from the preoperative value by more than three standard deviations of the method of analysis.
biliary tract surgery or with pre-existing liver disease was adversely affected by halothane. Minor increases in jaundice and changes in plasma enzyme levels would not have been detected by these studies.
Minor alterations of plasma enzymes are common in the first few days after surgery and may result from surgical trauma, hepatic hypoxia, hypotension and anaesthetic agents. In adults, several studies have shown that these initial elevations of serum enzymes result from insults to all body tissues including the liver and have usually returned to preoperative values by the fourth postoperative day.ls-17
Similar studies have not been performed in children but there is no reason to suspect that children would behave differently from adults. A study of 76 patients with unexplained jaundice after surgery and halothane anaesthesia by Walton and colleagues ls reported that the mean latent period between anaesthesia and the onset of jaundice was 6.6 days (range 1-23 days). In our study, plasma enzyme tests were taken four to eight days following surgery. This timing of blood collection would maximise the chance of identifying plasma enzyme elevations due to halothane and minimise the chance of any such elevations being secondary to tissue trauma, hepatic hypoxia and hypotension. In young children blood sampling can be a distressing, anxiety-provoking experience and it was decided that serial postoperative blood collections solely for the purposes of the study were inappropriate.
Small but significant elevations of both plasma AST and AL T values after surgery and halothane anaesthesia occurred in four of the 38 patients in TABLE 5 Changes in liver function tests following surgery and halothane anaesthesia in children with biliary atresia. Thesechildren were receiving treatment with phenobarbitone 2-3 mg.k![1 dayl to induce liver enzymes. TBr = total bilirubin. DBr = direct bilirubin. AST = asparate aminotransferase. ALT = alanine aminotransferase. GGT = gamma glutamyl transferase. SAP = serum alkaline phosphatase. ND = not done. pre = preoperative. post = postoperative. PCTHC = percutaneous transhepatic cholanigiogram. In seven of the 38 patients in the study there was never any elevation of plasma enzymes above the upper limit of the normal range, either pre-or postoperatively. Six of these patients had hepatic disease secondary to cystic fibrosis 22 . 23 and one infant had a primary hepatic neuroblastoma. It should be noted however, that the height of the elevation of plasma enzymes does not correlate with the extent ofliver cell necrosis evident on liver biopsy.20 In those patients where surgical relief of bile duct obstruction was accomplished, elevated preoperative plasma enzymes rapidly returned to normal despite the use of halothane.
Reductive metabolism of halothane is increased under hypoxic conditions and is postulated to cause hepatic injury.24-26 Twenty-one of the patients in the series had cystic fibrosis, mild to moderate respiratory disease and preoperative arterial haemoglobin saturations which varied from 91-97%. Brief periods of postoperative TABLE 6 Changes in liver function tests following surgery and halothane anaesthesia in children anaesthetised with halothane at least twice within a month. TBr = total bilirubin, DBr = direct bilirubin, AST = asparate aminotransferase, ALT = alanine aminotransferase, GGT = gamma glutamyl transferase, SAP = serum alkaline phosphatase, ND = not done, pre = preoperative, post = postoperative, PCTHC = percutaneous transhepatic cholanigiogram. desaturation secondary to pain, the sedative effects of narcotic analgesics and physiotherapy, are difficult to avoid in these patients. Following major upper abdominal surgery in patients with cystic fibrosis no clinically significant deterioration of liver function was observed. Enzyme induction is postulated to enhance the hepatotoxic potential of halothane even in the presence of normoxic conditions. Seven patients in the study had biliary atresia and were treated with phenobarbitone, a known enzyme inducer. 27 Another factor suggested to adversely affect liver function is repeat halothane anaesthesia at short intervals. 28 -3o . Fifteen patients had at least two halothane anaesthetics within a month without a deterioration of postoperative serum enzymes.
In a prospective study in rats, halothane, isoflurane and fentanyl were examined for their potential to exacerbate liver dysfunction in rats with pre-existing cirrhosis. 31 It was concluded that all anaesthetics used were associated with the same minimal degree of post-anaesthetic hepatic dysfunction and that the dysfunction was similar in both cirrhotic and non-cirrhotic rats. Maze and colleagues 32 found that 1.8% halothane did not result in superimposition of acute liver cell injury in already cirrhotic rats. In a later study from the same group,33 no difference was found in halothane metabolism between cirrhotic and non-cirrhotic rats. In this study serum AST and ALT levels increased 1.5-fold in the non-cirrhotic group and about 2.5-fold in the cirrhotic group after halothane anaesthesia. It was concluded that the exacerbation of liver dysfunction after halothane anaesthesia was most likely related to an indirect effect such as a change in liver blood flow rather than to toxic metabolites. The authors of these rat studies suggest that their results can probably be extrapolated to humans. They put forward the proposition that minor disturbances of liver function commonly occur after anaesthesia in humans with pre-existing liver disease and that the type of anaesthetic agent used does not influence the degree of postoperative liver dysfunction.
In the 38 children studied in our study, preexisting liver disease did not predispose to a deterioration of liver function following surgery and halothane anaesthesia.
